BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20338500)

  • 1. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation.
    Tsirka AE; Trinkaus K; Chen SC; Lipshultz SE; Towbin JA; Colan SD; Exil V; Strauss AW; Canter CE
    J Am Coll Cardiol; 2004 Jul; 44(2):391-7. PubMed ID: 15261937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
    Tallaj JA; Franco V; Rayburn BK; Pinderski L; Benza RL; Pamboukian S; Foley B; Bourge RC
    J Heart Lung Transplant; 2005 Dec; 24(12):2196-201. PubMed ID: 16364871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.
    Herrmann S; Schmidt-Petersen K; Pfeifer J; Perrot A; Bit-Avragim N; Eichhorn C; Dietz R; Kreutz R; Paul M; Osterziel KJ
    Eur Heart J; 2001 Oct; 22(20):1948-53. PubMed ID: 11601839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
    Domanski M; Coady S; Fleg J; Tian X; Sachdev V
    Am J Cardiol; 2007 May; 99(10):1448-50. PubMed ID: 17493477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in patients with suspected myocarditis.
    Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
    Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Gregori D; Moretti M; Driussi M; Aleksova A; Chersevani D; Sabbadini G; Sinagra G
    Ital Heart J; 2005 Sep; 6(9):721-7. PubMed ID: 16212073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of children following a first hospitalization for dilated cardiomyopathy.
    Hollander SA; Bernstein D; Yeh J; Dao D; Sun HY; Rosenthal D
    Circ Heart Fail; 2012 Jul; 5(4):437-43. PubMed ID: 22570362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.